Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.pathol.2019.01.011 | DOI Listing |
Urol Int
April 2024
Department of Urology, University Hospital of Tuebingen, Tuebingen, Germany.
Front Oncol
July 2023
Department of Urology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
Objective: The aim of this study is to investigate the clinical characteristics and diagnostic and therapeutic methods of bladder metastasis after radical prostatectomy and to improve its diagnosis and treatment.
Methods: The clinical data of four patients with bladder metastasis after radical prostatectomy were retrospectively analyzed from January 2011 to December 2021. Three cases suffered from intermittent gross hematuria, and only one case was found to have an elevated prostate-specific antigen (PSA) value.
Pathology
June 2019
Wollongong Hospital, Anatomical Pathology Department, Wollongong, NSW, Australia. Electronic address:
Arch Pathol Lab Med
July 2000
Division of Cytology, Department of Pathology, The University of Texas Medical Branch, Galveston, USA.
Context: Urethral adenomatous polyps with prostatic epithelium (also known as benign prostatic epithelial polyps [BPEPs]) are a documented cause of hematuria, dysuria, and hematospermia, conditions that may prompt cytologic evaluation of urine.
Design: The urine cytologic test findings in 5 cases of biopsy-proven BPEPs and in 1 case of prostatic ductal adenocarcinoma (PDA) that presented as a urethral polyp were retrospectively evaluated. Immunocytochemical stain for prostate-specific antigen (PSA), prostatic acid phosphatase (PAP), and high-molecular-weight cytokeratin (34betaE12) were used in evaluation of the lesions.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!